DEMİRER, T. Et Al. 2000. A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies. Bone Marrow Transplantation , vol.25, no.7 , 697-703.

DEMİRER, T., İLHAN, ., Mandel, N., Arat, M., Günel, N., ÇELEBİ, H., ... Üstün, C.(2000). A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies. Bone Marrow Transplantation , vol.25, no.7, 697-703.

DEMİRER, TANER Et Al. "A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies," Bone Marrow Transplantation , vol.25, no.7, 697-703, 2000

DEMİRER, TANER Et Al. "A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies." Bone Marrow Transplantation , vol.25, no.7, pp.697-703, 2000

DEMİRER, T. Et Al. (2000) . "A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies." Bone Marrow Transplantation , vol.25, no.7, pp.697-703.

@article{article, author={TANER DEMİRER Et Al. }, title={A phase I dose escalation study of high-dose thiotepa, melphalan and carboplatin (TMCb) followed by autologous peripheral blood stem cell transplantation (PBSCT) in patients with solid tumors and hematologic malignancies}, journal={Bone Marrow Transplantation}, year=2000, pages={697-703} }